Biomaker test for early sepsis identification

 5th May 2015

EKF Diagnostics, the global diagnostics company, announces that it has introduced the Stanbio Chemistry Procalcitonin (PCT) LiquiColor® assay.

This new test enables the quantitative determination of PCT in serum samples, EDTA or lithium heparin plasma samples by latex enhanced immunoturbidimetric methodology. Procalcitonin is a marker for bacterial infection and sepsis and has been recognized as an important adjunct marker in the diagnosis of sepsis*.

The new Stanbio Chemistry Procalcitonin (PCT) LiquiColor® Assay is fast, accurate and convenient.

The test provides a precise result, which correlates well with established methodology, within 10 minutes and requires just 20 µL of sample. The reagents may be used on almost any liquid-based chemistry analyzer with open-channel capability. In addition, the reagent kit, calibrator and control sets are all available separately. 

Commenting on the cost-effectiveness and convenience of the Stanbio Chemistry Procalcitonin (PCT) LiquiColor® Assay, Al Blanco, Business Unit Director ­ Central Laboratory at EKF Diagnostics said, “This assay can be performed on a customer’s existing chemistry analyzer with the same collection tube used for analysis of other chemistry tests. 

Therefore, it will provide optimized lab workflow by eliminating the need to split a sample or have a dedicated off-line workstation. These features will provide any lab with a cost-effective solution for PCT testing.”

*Not for sale in USA, Germany, Austria, France, Italy and Spain.